Letter: vedolizumab for the management of inflammatory bowel disease in patients after liver transplantation for primary sclerosing cholangitis

被引：13

作者：

Hartery, K. ^{[1
,2
]}

O'Reilly, S. ^{[1
,2
]}

Houlihan, D. ^{[2
,3
]}

Doherty, G. ^{[1
,2
]}

Mulcahy, H. ^{[1
,2
]}

Cullen, G. ^{[1
,2
]}

Sheridan, J. ^{[1
,2
]}

机构：

[1] St Vincents Univ Hosp, Ctr Colorectal Dis, Dept Gastroenterol, Dublin, Ireland

[2] Univ Coll Dublin, Sch Med, Dublin, Ireland

[3] St Vincents Univ Hosp, Natl Liver Unit, Dublin, Ireland

来源：

ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2017年 / 45卷 / 02期

关键词：

CASE SERIES; THERAPY;

D O I：

10.1111/apt.13861

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：376 / 378

页数：4

共 10 条

[1] Diagnosis and Management of Primary Sclerosing Cholangitis [J].

Chapman, Roger ;

Fevery, Johan ;

Kalloo, Anthony ;

Nagorney, David M. ;

Boberg, Kirsten Muri ;

Shneider, Benjamin ;

Gores, Gregory J. .

HEPATOLOGY, 2010, 51 (02) :660-678

[2] Vedolizumab in Inflammatory Bowel Disease Associated with Autoimmune Liver Disease Pre- and Postliver Transplantation: A Case Series [J].

Lim, Tiong Yeng ;

Pavlidis, Polychronis ;

Gulati, Shraddha ;

Pirani, Tasneem ;

Samaan, Mark ;

Chung-Faye, Guy ;

Dubois, Patrick ;

Irving, Peter ;

Heneghan, Michael ;

Hayee, Bu'Hussain .

INFLAMMATORY BOWEL DISEASES, 2016, 22 (10) :E39-E40

[3] Management of Ulcerative Colitis Using Vedolizumab After Liver Transplantation for Primary Sclerosing Cholangitis [J].

Meszaros, Magdalena ;

Pageaux, Georges-Philippe ;

Altwegg, Romain .

JOURNAL OF CROHNS & COLITIS, 2016, 10 (02) :236-236

[4] Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipients [J].

Mohabbat, A. B. ;

Sandborn, W. J. ;

Loftus, E. V., Jr. ;

Wiesner, R. H. ;

Bruining, D. H. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (06) :569-574

[5] The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation - a single-centre experience [J].

Moncrief, Karli J. ;

Savu, Anamaria ;

Ma, Mang M. ;

Bain, Vince G. ;

Wong, Winnie W. ;

Tandon, Puneeta .

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 24 (01) :40-46

[6] Antitumor necrosis treatment in primary sclerosing cholangitis associated inflammatory bowel disease after liver transplantation [J].

Pavlidis, Polychronis ;

Potts, Jonathan ;

Barnabas, Ashley ;

Heaton, Nigel ;

Bjarnason, Ingvar ;

Heneghan, Michael ;

Hayee, Bu'Hussain .

LIVER TRANSPLANTATION, 2015, 21 (11) :1455-1456

[7] Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease [J].

Sandborn, William J. ;

Feagan, Brian G. ;

Rutgeerts, Paul ;

Hanauer, Stephen ;

Colombel, Jean-Frederic ;

Sands, Bruce E. ;

Lukas, Milan ;

Fedorak, Richard N. ;

Lee, Scott ;

Bressler, Brian ;

Fox, Irving ;

Rosario, Maria ;

Sankoh, Serap ;

Xu, Jing ;

Stephens, Kristin ;

Milch, Catherine ;

Parikh, Asit .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (08) :711-721

[8] The safety and efficacy of antitumour necrosis factor-alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series [J].

Sandhu, A. ;

Alameel, T. ;

Dale, C. H. ;

Levstik, M. ;

Chande, N. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (02) :159-165

[9] Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort [J].

Schnitzler, Fabian ;

Friedrich, Matthias ;

Stallhofer, Johannes ;

Schoenermarck, Ulf ;

Fischereder, Michael ;

Habicht, Antje ;

Karbalai, Nazanin ;

Wolf, Christiane ;

Angelberger, Marianne ;

Olszak, Torsten ;

Beigel, Florian ;

Tillack, Cornelia ;

Goeke, Burkhard ;

Zachoval, Reinhart ;

Denk, Gerald ;

Guba, Markus ;

Rust, Christian ;

Gruener, Norbert ;

Brand, Stephan .

PLOS ONE, 2015, 10 (08)

[10] Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study [J].

Stallmach, A. ;

Langbein, C. ;

Atreya, R. ;

Bruns, T. ;

Dignass, A. ;

Ende, K. ;

Hampe, J. ;

Hartmann, F. ;

Neurath, M. F. ;

Maul, J. ;

Preiss, J. C. ;

Schmelz, R. ;

Siegmund, B. ;

Schulze, H. ;

Teich, N. ;

von Arnim, U. ;

Baumgart, D. C. ;

Schmidt, C. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (11-12) :1199-1212

← 1 →